{"version":"1.0","type":"link","title":"Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial.","author_name":"Novello S 외","author_url":"https://prs-insight.online/author/Novello%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98157","thumbnail_width":1200,"thumbnail_height":630}